Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Bioinformatics is defined as the combination of biology and information technology. Computer software tools are used in bioinformatics for creation, management and development of database. It is also used in data warehousing, data mining and communication networking. In addition, it is widely used in the management of biological information in the field of medical research and development of drugs.

Statistics:

The global bioinformatics market is estimated to account for US$ 46,261.2 Mn in terms of value by the end of 2027.

Global Bioinformatics Market: Drivers

Significant growth in the pharmaceutical sector is expected to propel growth of the global bioinformatics market over the forecast period. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 139, 287 million in 2000, which increased to US$ 284, 028 million (est.) in 2018.

Moreover, various advantages of bioinformatics are also expected to aid in growth of the market. Various advantages of bioinformatics include, convenient and accurate verification of biological data, and storage and access to a large amount of data. Bioinformatics also helps in fast sequence search through algorithm. In addition, bioinformatics is also used in the field of biotechnology such as blue biotechnology, green biotechnology, red biotechnology, white biotechnology, and bioeconomics. It is cost effective and includes pharmacogenomics, drug productions, genetic testing, and gene therapy.

Statistics:

North America held dominant position in the global bioinformatics market in 2019, accounting for 35.9% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Bioinformatics Market Share (%) Value, By Region, 2019

Bioinformatics  | Coherent Market Insights

Global Bioinformatics Market: Restraints

High capital investment is expected to hinder growth of the global bioinformatics market. Moreover, lack of skilled professionals and low adoption of bioinformatics in emerging economies is also expected to limit the market growth.

request-sample

Bioinformatics Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 10,391.4 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 20.5% 2027 Value Projection: US$ 46,261.2 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Product: Bioinformatics Platforms, Bioinformatics Services.
  • By Application: Genomics, Chemoinformatics and drug design, Proteomics, Transcriptomics, Metabolomics, Molecular Phylogenomics, Others.
Companies covered:

Active Motif, Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare, Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced BioInformatics GmbH, and Fios Genomics Ltd.

Growth Drivers:
  • Increasing adoption of bioinformatics in pharmaceutical industry
Restraints & Challenges:
  • High capital investment

Statistics:

The global bioinformatics market was valued at US$ 10,391.4 Mn in 2019 and is forecast to reach a value of US$ 46,261.2 Mn by 2027 at a CAGR of 20.5% between 2020 and 2027.

Figure 2: Global Bioinformatics Market Value (US$ Mn), 2016 – 2027

Bioinformatics  | Coherent Market Insights

Market Trends/Key Takeaways

Grants for R&D in bioinformatics is expected to propel growth of the global bioinformatics market. For instance, in August 2020, Addex Therapeutics, a clinical-stage pharmaceutical company, and the Swiss Institute of Bioinformatics were awarded a US$ 656 thousands Innosuisse grant to apply computational approaches developed by Swiss Institute of Bioinformatics to identify new therapeutic indications for ADX10061, a potent and selective dopamine D1 receptor antagonist.

Moreover, adoption of bioinformatics in R&D of COVID-19 is also expected to aid in growth of the market. For instance, August 2020, researchers from University of Pennsylvania, U.S., reported that a new bioinformatics approach to studying the pathogenesis of COVID-19, by uncovering the differentially expressed genes and cell signaling pathways that cause the disease characteristics.

Global Bioinformatics Market: Competitive Landscape

Major players operating in the global bioinformatics market include, Active Motif, Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare, Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced BioInformatics GmbH, and Fios Genomics Ltd.

Global Bioinformatics Market: Key Developments

Major players in the global bioinformatics market are focused on R&D to expand their product portfolio. For instance, in June 2020, Intomics announced that the company is a part of the newly funded translate project on personalized diabetes treatment. As part of the TRANSLATE project funded by the Innovation Fund Denmark, Intomics will develop a new software platform facilitating personalised treatment of diabetes patients.

Major players in the market are also focused on raising funds to enhance their market share. For instance, in September 2020, bitBiome, Inc. raised US$ 6.6 million in a Series B financing from previous and new investors including The University of Tokyo Edge Capital Partners, Universal Materials Incubator, and other Japan-based venture capital firms.

Bioinformatics software and tools are being used as integrated solutions that provide algorithms and statistical procedures for data analysis and integration. Bioinformatics is used in data warehousing, data mining and communication networking along with management of biological information in the field of medical research and development of drugs. Major advantages associated with the use of bioinformatics in healthcare industry comprises of convenient and accurate verification of biological data, and storage and access to a large amount of data. Increasing adoption of bioinformatics in pharmaceutical industry along with increasing investment in research and development is anticipated to propel the market growth during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Global Bioinformatics market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Bioinformatics market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Active Motif, Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare, Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced BioInformatics GmbH, and Fios Genomics Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Bioinformatics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Bioinformatics market

Detailed Segmentation:

  • Global Bioinformatics Market, By Product:
    • Bioinformatics platforms
    • Bioinformatics services
  • Global Bioinformatics Market, By Application:
    • Genomics
    • Chemoinformatics and drug design
    • Proteomics
    • Transcriptomics
    • Metabolomics
    • Molecular Phylogenomics
    • Others
  • Global Bioinformatics Market, By Region:
    • North America
      • By Application:
        • Genomics
        • Chemoinformatics and drug design
        • Proteomics
        • Transcriptomics
        • Metabolomics
        • Molecular Phylogenomics
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product
        • Bioinformatics platforms
        • Bioinformatics services
      • By Application:
        • Genomics
        • Chemoinformatics and drug design
        • Proteomics
        • Transcriptomics
        • Metabolomics
        • Molecular Phylogenomics
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product
        • Bioinformatics platforms
        • Bioinformatics services
      • By Application:
        • Genomics
        • Chemoinformatics and drug design
        • Proteomics
        • Transcriptomics
        • Metabolomics
        • Molecular Phylogenomics
        • Others
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product
        • Bioinformatics platforms
        • Bioinformatics services
      • By Application:
        • Genomics
        • Chemoinformatics and drug design
        • Proteomics
        • Transcriptomics
        • Metabolomics
        • Molecular Phylogenomics
        • Others
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product
        • Bioinformatics platforms
        • Bioinformatics services
      • By Application:
        • Genomics
        • Chemoinformatics and drug design
        • Proteomics
        • Transcriptomics
        • Metabolomics
        • Molecular Phylogenomics
        • Others
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Product
        • Bioinformatics platforms
        • Bioinformatics services
      • By Application:
        • Genomics
        • Chemoinformatics and drug design
        • Proteomics
        • Transcriptomics
        • Metabolomics
        • Molecular Phylogenomics
        • Others
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Active Motif, Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Illumina, Inc.
    • Life Technologies
    • Affymetrix, Inc.
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc.
    • Qiagen
    • Knome, Inc.
    • GE Healthcare
    • Geneva Bioinformatics SA
    • Quest Diagnostics
    • bitBiome, Inc.
    • Intomics
    • Advanced BioInformatics GmbH
    • Fios Genomics Ltd
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Application
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Bioinformatics Market, By Product, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Bioinformatics Platforms
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bioinformatics Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Bioinformatics Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Genomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chemoinformatics and drug design
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Proteomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Transcriptomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Metabolomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Molecular Phylogenomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Bioinformatics Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Active Motif, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Life Technologies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Affymetrix, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Agilent Technologies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Qiagen
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Knome, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GE Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Geneva Bioinformatics SA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Quest Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • bitBiome, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Intomics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Advanced BioInformatics GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fios Genomics Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Bioinformatics Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Bioinformatics market size was valued at US$ 10,391.4 million in 2019 and is estimated to exhibit a CAGR of 20.5% between 2020 and 2027.
Genomics segment held the major market share in 2019 owing to an increasing prevalence of chronic disorders along with rapid increase in pharmaceutical industry is expected to propel growth of the market.
Major factor driving the growth of Global Bioinformatics market during the forecast period increasing prevalence of chronic disorders, increasing adoption of bioinformatics in development of pharmaceuticals, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Bioinformatics market during the forecast period constitutes of contamination of high investment cost.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Active Motif, Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare, Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced BioInformatics GmbH, and Fios Genomics Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner